| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |